Related Experiment Videos
[Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotype
T van Veen1, L van Winsen, J B A Crusius
1Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. T.vanveen@VUMC.NL
Neurology
|November 12, 2003
Summary
Genetic variations in the CRYAB gene influence multiple sclerosis (MS) susceptibility and disease presentation. Specific CRYAB polymorphisms are linked to a noninflammatory, neurodegenerative MS phenotype.
Area of Science:
- Neuroimmunology
- Human Genetics
Background:
- Multiple sclerosis (MS) susceptibility and clinical phenotype have genetic components.
- Alpha-B-crystallin (CRYAB) is a potential autoantigen in MS.
- Three promoter polymorphisms exist in the CRYAB gene: -C249G, -C650G, and -A652G.
Purpose of the Study:
- To investigate the role of CRYAB gene polymorphisms in MS.
- To assess the impact of these polymorphisms on disease susceptibility.
- To evaluate their influence on clinical phenotype and MRI findings in MS.
Main Methods:
- Study design involved sporadic MS cases.
- Analysis focused on three specific CRYAB promoter polymorphisms.
- Outcomes measured included disease susceptibility, clinical phenotype, and MRI appearance.
Main Results:
- CRYAB polymorphisms were found to affect MS susceptibility.
- These genetic variations also influenced disease expression in MS patients.
- The CRYAB-650*C allele was associated with disease characteristics.
Conclusions:
- Carriers of the rare CRYAB-650*C allele showed a higher probability of a noninflammatory, neurodegenerative MS phenotype.
- This phenotype is characterized by a primary progressive clinical disease course.
- Genetic factors, specifically CRYAB polymorphisms, play a role in MS pathogenesis and clinical variability.